1. Home
  2. ZLAB vs TWST Comparison

ZLAB vs TWST Comparison

Compare ZLAB & TWST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Zai Lab Limited

ZLAB

Zai Lab Limited

N/A

Current Price

$25.53

Market Cap

2.6B

Sector

Health Care

ML Signal

N/A

Logo Twist Bioscience Corporation

TWST

Twist Bioscience Corporation

N/A

Current Price

$191.41

Market Cap

9.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ZLAB
TWST
Founded
2013
2013
Country
China
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.6B
9.2B
IPO Year
2017
2018

Fundamental Metrics

Financial Performance
Metric
ZLAB
TWST
Price
$25.53
$191.41
Analyst Decision
Strong Buy
Buy
Analyst Count
12
13
Target Price
$33.14
★ $109.58
AVG Volume (30 Days)
698.4K
★ 1.7M
Earning Date
11-05-2026
11-13-2026
Dividend Yield
N/A
N/A
EPS Growth
38.46
★ 63.89
EPS
★ N/A
N/A
Revenue
★ $460,156,000.00
$376,572,000.00
Revenue This Year
N/A
$21.19
Revenue Next Year
$26.50
$18.41
P/E Ratio
★ N/A
N/A
Revenue Growth
15.33
★ 20.32
52 Week Low
$15.96
$23.30
52 Week High
$34.07
$191.00

Technical Indicators

Market Signals
Indicator
ZLAB
TWST
Relative Strength Index (RSI) 58.51 74.21
Support Level $24.81 $41.18
Resistance Level $27.20 N/A
Average True Range (ATR) 0.77 11.40
MACD -0.03 3.59
Stochastic Oscillator 76.31 96.37

Price Performance

Historical Comparison
ZLAB
TWST

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. Zai Lab has a diverse pipeline of potentially first-in-class product candidates developed through in-house R&D and global partnerships. The company has successfully commercialized several products in China, including Zejula, Optune, Qinlock, and Nuzyra, with plans for further expansion The pipeline of proprietary drug candidates of the company includes ZL-1222, ZL-1311, ZL-6201 and many others.

About TWST Twist Bioscience Corporation

Twist Bioscience Corp is a synthetic biology company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's proprietary semiconductor-based manufacturing process synthesizes DNA on silicon rather than traditional plastic plates, enabling the production of high-quality synthetic DNA faster, more affordably, and at scale. This platform overcomes conventional inefficiencies, supports cost-effective, high-throughput synthesis, and allows researchers to accelerate innovation. Geographically, the company operates across the Americas, EMEA, and APAC, deriving the majority of its revenue from the Americas.

Share on Social Networks: